Market Announcements
Market Summary
New Zealand blue-chip equities closed firmer on Monday as buyers outnumbered sellers, with gains among Tourism Holdings, Pacific Edge and Fisher & Paykel Healthcare supporting the overall direction. At the close the S&P/NZX 50 Index was up 0.84% or 111.91 points to 13,420.43. Both the S&P/NZX 10 and S&P/NZX 20 ended higher. Turnover was $111,935,160 on volume of 30,849,521 shares.
“It’s really a story of results,” said Hamilton Hindin Greene investment adviser Grant Davies, observing that the top 50 index had opened up and held gains. Tourism Holdings gained 10.83% to $2.66 as it turned in a 17% full-year rise in statutory net profit after tax to $29.6 million. Revenue was up, and it noted significant progress in strategic initiatives. “Tourism Holdings has produced a good update,” said Davies, who had observed several exporters doing well in recent times.
Fisher & Paykel Healthcare ended Monday up 3.83% to $38.75. Fisher & Paykel Healthcare lifted its revenue and earnings guidance for the year to March 31, not including any potential refund of US tariffs paid to date during the 2026 financial year. “They’ve narrowed their guidance, which is pretty good,” said Davies, regarding this as a “pretty solid” outcome and one that shrugged off concerns around tariffs.
Pacific Edge added 6.67% to 24 cents after its shares resumed trading on Monday. The cancer diagnostics company’s urine-based biomarker test for evaluating haematuria was well received by a panel of experts organised by US firm Novitas Solutions.
Other risers included Heartland Group, Skellerup, Eroad, Chorus and Skycity Entertainment. Davies noted that a stronger than expected uptick in seasonally adjusted retail sales volumes for the three months to end-December 2025 had failed to fire the market. The rise of 0.9% came after a 1.9% gain in the September quarter, suggesting the beleaguered retail sector was starting to find its feet as the economy showed signs of fragile recovery.
To the downside, aged-care care continued to be under pressure. Summerset Group shed 1.81% to $10.31, while Ryman Healthcare fell 2.42% to $2.42 and Oceania Healthcare ebbed 1.82% to 81c. “The rationale for that is the property market has been a little bit on the softer side,” said Davies. “So we’ve seen the continuation of Summerset, Ryman and Oceania being sold off today. It’s probably the most negative area of the [NZX] 50,” he told BusinessDesk.
Further drag on the market came among gentailers such as Meridian Energy off earlier lows to be flat at $5.61, Contact Energy off 0.32% to $9.22, and Mercury NZ shy 0.32% to $6.15, this came on the back of Genesis Energy’s $400m capital hike. “Genesis is not trading, but obviously investors [are] tapping into other gentailers to raise funds for that,” Davies said.
Source: Business Desk
Australian Market Report
Ahead of the local open SPI futures were 27 points higher at 9004.
- close [Morningstar with AAP]: Australia's share market has retreated from the previous week's record high as investors weigh the latest twist in the Trump tariff saga.
The S&P/ASX200 fell 55.4 points on Monday, down 0.61 per cent to 9,026, as the broader All Ordinaries gave up 51.7 points, or 0.56 per cent, to 9,251.5.
Gold miners were a lonely success story, helping lift the basic materials sector 1.2 per cent as investors sought safe havens following US President Donald Trump's threat to lift global tariffs to 15 per cent after a US court ruled against his previous tariffs.
While local markets got off to a shaky start, the impacts on Australia's economy should be minor, IG Market analyst Tony Sycamore said.
"It doesn't really impact our GDP (gross domestic product) given we don't have a huge export sector to the US," he told AAP.
"This isn't a toxic outcome for the Australian stock market or for Australian exporters net-net, and it may actually turn out to be a boon because China, where most of our exports go, has gotten out of it with a lower effective tariff rate."
Only three of 11 local sectors ended the session higher, led by a 1.5 per cent boost to basic materials as investors ploughed back into gold stocks.
Spot gold is buying $US5,156 ($A7,294) an ounce, supporting names such as Evolution Mining and Northern Star, which each rallied 3.5 per cent.
Iron ore giants were mixed, with BHP lifting to its best-ever closing price of $54.02, while Rio Tinto and Fortescue fell behind.
Lynas Rare Earths ticked higher ahead of its earnings update later in the week and lithium producers Liontown and PLS each gained more than three per cent.
Financials were heavy, down 1.2 per cent as all four banks sold off, led by a 2.3 per cent slump in ANZ shares.
Commonwealth Bank lost 0.6 per cent to $178.53, but has held onto most of its recent earnings season gains.
Energy stocks tumbled 1.7 per cent despite oil prices hovering near recent highs as tensions between Iran and the US persist.
Coal producers were also in the red while uranium stocks ran into profit-taking after strong performances the previous week.
Ampol shares faded more than two per cent as its first-half statutory net profit after tax fell by roughly a third on the equivalent half to $82.4 million.
IT stocks were the worst-performing segment, down 4.6 per cent despite a positive lead from Wall Street on Friday, as concerns about artificial intelligence disruption to software companies loomed.
Health care was also under pressure, the sector losing 2.4 per cent as CSL tanked to its lowest price in more than six years.
The slip came despite strong earnings and guidance from Fisher and Paykel Healthcare (up 4.0 per cent) and Regis Healthcare (up 7.6 per cent).
Consumer cyclical stocks gave up almost 1.8 per cent in a broad-based slump that overshadowed positive earnings reports from Kogan (up 5.5 per cent) and Adairs (up 10.5 per cent).
Looking ahead, earnings season continues with Woolworths and Nine Entertainment among companies reporting on Tuesday and Fortescue, Yancoal, Domino's and Qantas to follow later in the week.
The Australian dollar is buying 70.74 US cents, up from 70.43 US cents on Friday afternoon.
January inflation figures come out on Wednesday, and any upward surprise in price growth could significantly increase the odds of a Reserve Bank interest rate cut in March.
ON THE ASX:
The S&P/ASX200 fell 55.4 points, or 0.61 per cent, to 9,026
The broader All Ordinaries lost 51.7 points, or 0.56 per cent, to 9,251.5
The NZX 50 Lost -31.13 points (-0.23%) to 13389.3
Companies commencing Ex-Dividend Trading Today (ASX 300):
AGL Energy Limited
Amcor Plc
Bega Cheese Limited
Challenger Limited
Deterra Royalties Limited
MA Financial Group Limited
Ventia Services Group Limited
Wesfarmers Limited
Overseas Market Report
[Morningstar with Dow Jones]:
U.S. stocks ended lower. The DJIA slipped 1.7% to 48,804.06, the S&P 500 declined 1% to 6,837.75 and the Nasdaq dropped 1.1% to 22,627.27.
Among S&P 500 companies, the top three gainers were PayPal Holdings Inc PYPL surging 5.81%, Albemarle Corp ALB jumped 5.41%, and Akamai Technologies Inc AKAM lifted 5.06%.
The biggest decliners were International Business Machines Corp IBM which dropped 13.41%, Datadog Inc DDOG fell 11.47%, and CrowdStrike Holdings Inc CRWD lost 10.02%.
Asia
Chinese shares closed lower. The benchmark Shanghai Composite Index slipped 1.3% to 4,082.07 and the Shenzhen Composite Index slipped 1.1% to 2,680.39.
Hong Kong shares ended higher. The benchmark Hang Seng Index rose 2.5% to 27,081.91.
Japanese shares ended lower. The Nikkei Stock Average declined 1.1% to 56,825.70.
India shares ended higher. The BSE SENSEX rose 0.6% to 83,294.66.
Europe
Stocks in the U.K. finished flat. The FTSE 100 Index was unchanged at 10,684.74. In Europe, shares closed lower. The Germany's DAX dropped 1.1% to 24,991.97, and the France's CAC 40 declined 0.2% to 8,497.17
